Neurogene

Neurogene

Focused on developing life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.

HQ location
New York City, United States
Launch date
Employees
Enterprise value
$460—690m
Share price
$0.00 NEUN
Recent deals
Authorizing premium user...